BioRestorative Therapies, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
BioRestorative Therapies, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2024.
  • BioRestorative Therapies, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $1.2M, a 84.8% decline year-over-year.
  • BioRestorative Therapies, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $2.44M, a 81.8% decline year-over-year.
  • BioRestorative Therapies, Inc. annual Nonoperating Income (Expense) for 2023 was $4.8M, a 16.5% decline from 2022.
  • BioRestorative Therapies, Inc. annual Nonoperating Income (Expense) for 2022 was $5.75M.
  • BioRestorative Therapies, Inc. annual Nonoperating Income (Expense) for 2021 was -$18M, a 111% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.44M $1.2M -$6.68M -84.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $9.12M -$1.56M +$1.03M +39.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $8.08M $1.89M +$3.28M Jan 1, 2024 Mar 31, 2024 10-Q 2024-06-11
Q4 2023 $4.8M $917K -$8.57M -90.3% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-06-11
Q3 2023 $13.4M $7.87M +$7.04M +841% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $6.34M -$2.59M +$5.14M +66.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $1.2M -$1.39M -$4.55M -144% Jan 1, 2023 Mar 31, 2023 10-Q 2024-06-11
Q4 2022 $5.75M $9.49M +$25.9M Oct 1, 2022 Dec 31, 2022 10-K/A 2024-06-11
Q3 2022 -$20.1M $837K +$1.33M Jul 1, 2022 Sep 30, 2022 10-K/A 2024-06-11
Q2 2022 -$21.5M -$7.73M -$7.22M -1423% Apr 1, 2022 Jun 30, 2022 10-K/A 2024-06-11
Q1 2022 -$14.2M $3.15M +$3.75M Jan 1, 2022 Mar 31, 2022 10-K/A 2024-06-11
Q4 2021 -$18M -$16.4M +$1.97M +10.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 -$20M -$496K -$270K -119% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$19.7M -$507K -$3.84M -115% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$15.9M -$599K -$7.33M -109% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$8.52M -$18.4M -$19M -3134% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $10.4M -$226K +$3.01M +93% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $7.44M $3.34M +$5.37M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $2.07M $6.73M +$8.29M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$6.22M $605K +$2M Oct 1, 2019 Dec 31, 2019 10-K 2021-04-30
Q3 2019 -$8.21M -$3.24M -$1.5M -86.5% Jul 1, 2019 Sep 30, 2019 10-Q 2021-04-12
Q2 2019 -$6.71M -$2.03M -$564K -38.5% Apr 1, 2019 Jun 30, 2019 10-Q 2021-04-12
Q1 2019 -$6.15M -$1.55M -$1.28M -461% Jan 1, 2019 Mar 31, 2019 10-Q 2021-03-29
Q4 2018 -$4.87M -$1.39M -$1.11M -385% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-18
Q3 2018 -$3.76M -$1.74M -$1.43M -463% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$2.34M -$1.46M -$1.29M -722% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$1.05M -$277K +$19.5K +6.57% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$1.07M -$287K -$90.3K -45.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 -$980K -$308K -$190K -160% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$790K -$178K -$62.9K -54.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$727K -$296K +$124K +29.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$851K -$197K +$130K +39.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$982K -$119K +$15.3K +11.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$997K -$115K +$42.2K +26.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$1.04M -$420K -$286K -213% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$753K -$328K -$160K -95.3% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-22
Q3 2015 -$593K -$134K +$70.5K +34.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-15
Q2 2015 -$664K -$157K -$106K -205% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$558K -$134K +$107K +44.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$665K -$168K +$253K +60.2% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$919K -$204K -$30.4K -17.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-23
Q2 2014 -$888K -$51.7K +$85.7K +62.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$974K -$241K +$25.2K +9.44% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$999K -$421K -$206K -95.7% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 -$793K -$174K +$97.9K +36% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$891K -$137K +$170K +55.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$1.06M -$266K -$96.3K -56.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$964K -$215K -$116K -116% Oct 1, 2012 Dec 31, 2012 10-K 2014-04-11
Q3 2012 -$848K -$272K -$112K -69.5% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-19
Q2 2012 -$737K -$307K -$140K -84.2% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-19
Q1 2012 -$597K -$170K -$74.7K -78.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$522K -$99.5K Oct 1, 2011 Dec 31, 2011 10-K 2013-04-02
Q3 2011 -$160K -$142K -763% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-05
Q2 2011 -$167K -$148K -798% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$95.5K Jan 1, 2011 Mar 31, 2011 10-Q/A 2012-06-01
Q3 2010 -$18.6K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
Q2 2010 -$18.6K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.